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Objectives: Bloodstream infections (BSI) are a serious cause of morbidity and mortality worldwide.
Emerging antimicrobial drug resistance among bacterial pathogens causing BSI can limit therapeutic
options and complicate patient management. This retrospective study was conducted to determine
trends in Salmonella BSI and antibiotic susceptibility patterns over 6 years (2008e2013) in a tertiary care
hospital in Dhaka, Bangladesh.
Methods: A total of 3584 blood samples were collected from patients with clinically diagnosed enteric
fever at Dhaka Medical College Hospital, Dhaka from January 2008 to December 2013. Isolates of
Salmonella enterica serovars Typhi and Paratyphi were identiﬁed by standard microbiological and
biochemical procedures.
Results: A total of 168 isolates of S. enterica serovar Typhi and 160 isolates of S. enterica serovar Paratyphi
were found. The average prevalence rate of Salmonella in the blood was 9.15%. Young patients, neonates,
and elderly individuals were more prone to Salmonella infection than other patients, and females were
more susceptible to Salmonella septicemia than males. Among Salmonella spp. isolates, 20.92% were
multidrug resistant and showed high resistance against amoxicillin, trimethoprimesulfamethoxazole,
ciproﬂoxacin, nalidixic acid, and chloramphenicol. Resistance rates to ceﬁpime, ceﬁxime, and ceftriaxone
are increasing slowly. Among Salmonella spp. isolates, 57.01% showed extended-spectrum b-lactamase
production capability.
Conclusion: Speciﬁc antibiotic utilization strategies such as antibiotic restriction, combination therapy
and usage according to standard antimicrobial susceptibility testing may help decrease or prevent the
emergence of resistance and incidence of BSI.
Copyright © 2014, Buddhist Compassion Relief Tzu Chi Foundation. Published by Elsevier Taiwan LLC. All
rights reserved.1. Introduction
Salmonella is an enteropathogenic microorganism that causes
infection accompanied by different clinical manifestations, most
commonly gastroenteritis and fever [1]. Salmonella bloodstream
infections (BSI) represent a major health problem worldwide but
particularly in developing countries such as Bangladesh [2e5]. Eachgy, Faculty of Sciences, Pri-
.
elief Tzu Chi Foundation. Publisheyear, there are 12e33 million cases of typhoid fever worldwide. BSI
cause signiﬁcant morbidity and mortality worldwide and are
among the most common health care-associated infections [6].
Microorganisms present in circulating blood, whether continuously
or intermittently, are a threat to every organ in the body. Illnesses
associated with BSI range from self-limiting infections to life-
threatening sepsis that requires rapid and aggressive antimicrobial
treatment [7].
Treatment of Salmonella infection has become challenging
because of emerging antibiotic resistance to ﬁrst-line antibiotics
such as chloramphenicol, ampicillin, sulphamethoxazole-
trimethoprim, and, more recently, the ﬂuoroquinolones [8]. Thed by Elsevier Taiwan LLC. All rights reserved.
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resistance to ﬂuoroquinolones and third-generation cephalospo-
rins is a serious problem that results in severe limitation of the
possibilities for effective treatment of human infections [9,10]. The
appearance of MDR Salmonella enterica serovar Typhi (SEST) has
resulted in a pressing need to test newer antimicrobials, develop
their dose regimens for the treatment of typhoid fever [11], and ﬁnd
the mechanism by which they acquire resistance [12].
Nowadays, bacterial drug resistance is an important problem.
Because of the wide variations in this resistance, the results of
studies and reports in one region or in one period of time are not
necessarily true for other regions or periods of time [13]. Drug
resistance is related to a series of social, environmental, and tech-
nological changes. Because of constantly evolving antimicrobial
resistant patterns, there is need for constant antimicrobial sensi-
tivity surveillance [14]. The determination of antibiotic sensitivity
patterns at periodic intervals is mandatory in each region for cli-
nicians to be aware of emerging pathogens that pose a threat to the
community, provide safe and effective empirical therapies, develop
rational prescribing practices and policy decisions in a hospital and
ﬁnally assess the effectiveness of all [15]. Appropriate surveillance
by monitoring antimicrobial drug susceptibility trends is a pre-
requisite to implementing rational measures to tackle the resis-
tance problem [16].
The aim of our study was to assess the prevalence of Salmonella
serotypes in a tertiary care hospital in Dhaka, Bangladesh. We
determined the predominant serotypes and resistance proﬁles of
Salmonella spp. strains isolated from patients over a period of 6
years (2008e2013) at a hospital that receives patients from
different parts of the country.
2. Materials and methods
2.1. Duration and place of study
This study was conducted on 3584 samples of blood collected
from patients with clinically diagnosed enteric fever at Dhaka
Medical College Hospital, Dhaka from January 2008 to December
2013. Blood samples were collected from patients suspected of
having septicemia and typhoid fever admitted to Dhaka Medical
College Hospital. The age of the patients in this study ranged from 2
years to 61 years. The population under study included both male
and female patients. With the permission of the hospital authority
and institutional ethical review committee, informed consent was
obtained from each participant. In the case of young patients (<20
years), consent was obtained from parents/legal guardians.
2.2. Collection of blood samples
The skin at the venipuncture site of the patient was ﬁrst cleaned
with 95% alcohol. A 10 mL sample of blood was drawn into a 10 mL
disposable pyrogen free syringe. A 5 mL sample of blood was
inoculated into a blood culture bottle containing 45 mL of
braineheart infusion broth. These bottles were immediately
transported to the laboratory [17].
2.3. Isolation of S. enterica serovars
Blood cultures bottles were incubated aerobically at 37C for 1
week. These bottles were examined daily throughout the week of
incubation. When growth appeared on any of the medium, a Gram
stain ﬁlm was made. If Gram-negative bacilli were detected, the
culture from the blood culture bottle was inoculated onto a blood
agar, xylose lysine deoxycholate agar, and a MacConkey's agar plate
[10].2.4. Biochemical identiﬁcation of serovars
The API 20E identiﬁcation system was used for biomedical
identiﬁcation of SEST and Salmonella enterica serovar Paratyphi
(SESP). The system consists of a plastic strip with 20 microtubes
containing dehydrated substrate of orthonitrophenyl-
galactopyranoside. The incubation box was prepared by putting
5 mL of sterile water into the honeycombed wells of the tray to
create a humid chamber. The strip was then place in the tray. A
single isolated colony of suspected Salmonella was picked up from
MacConkey's plate. It was emulsiﬁed in sterile saline to achieve a
homogenous bacterial suspension. With a sterile pipette, the tubes
and cupules of citrate, VogeseProskauer and gelatin were ﬁlled
with bacterial suspension. The remaining tubes and cupules were
ﬁlled with bacterial suspension. An anaerobic environment was
created in the arginine dihydrolase, lysine decarboxylase, ornithine
decarboxylase, urease, and hydrogen sulﬁde tests by overlaying
with mineral oil. The box was closed and incubated at 37C for 24
hours. A MacConkey agar plate was inoculated with the same ho-
mogenous bacterial suspension to check the purity of the bacterial
suspension and incubated at 37C for 24 hours.
2.5. Serological identiﬁcation of SEST and SESP
Anti-Salmonella agglutinating sera contain SEST and SESP A,
SESP B, SESP C, and SESP Vi from BioMerieux (Marcy l'Etoile, France)
were used. The Kauffmann and White scheme was followed for
serological conﬁrmation of SEST and SESP. One drop of aggluti-
nating serum was placed on a clean glass slide. One colony of the
test strain of Salmonella was picked up with a loop from the Mac-
Conkey agar plate. This bacterial culture and agglutinating serum
were mixed slowly with a sterile stick. When fully mixed, the slide
was rotated for 5e10 seconds. The agglutination was examined by
the naked eye. Positive and negative controls were tested in a
similar way on the same slide [18].
2.6. Antibiotic susceptibility testing
All the Salmonella spp. (328) strains were tested for antibiotic
resistance by the standard agar disc diffusion technique [19] on
MuellereHinton agar (HiMedia Laboratories Pvt. Ltd., Mumbai,
India) using commercial discs (Oxoid, Basingstoke, Hampshire, UK).
The following antibiotics with the disc strength in parentheses
were used: amoxicillin (10 mg), ciproﬂoxacin (5 mg), ceﬁpime
(30 mg), ceftriaxone (30 mg), ceﬁxime (5 mg), chloramphenicol
(50 mg), meropenem (10 mg), trimethoprimesulfamethoxazole
(25 mg), and nalidixic acid (30 mg). A control strain of Escherichia coli
ATCC 25922 was included in each plate. Antimicrobial breakpoints
and interpretations were taken from standards of the Clinical and
Laboratory Standards Institute [20]. Isolates resistant to three or
more drugs were classiﬁed as MDR.
2.7. Detection of extended-spectrum b-lactamase by the double disc
diffusion method
Positive (Klebsiella pneumoniae ATCC 700603) and negative
(E. coli ATCC 25922) control strains were inoculated onto Mul-
lereHinton agar. An amoxicillineclavulanic acid (20 mg and 10mg)
disc was placed on the center of the plate. Ceftazidime (30 mg),
ceftriaxone (30 mg), cefotaxime (30 mg), and aztreonam (30 mg)
discs were placed peripherally away from the amoxicillin-
clavulanic acid disc. After 24 hours of incubation at 37C, band
formation between the amoxicillin clavulanic acid disc and any
other disc was considered extended-spectrum b-lactamase (ESBL)
positive. The ESBL positive strains were further subjected to
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tained third-generation cephalosporins both with and without
clavulanic acid. The discs used included cefotaxime (30 mg), cefo-
taxime and clavulanic acid (30mg and 10mg), ceftazidime (30mg),
ceftazidime (30 mg and 10 mg), aztreonam (10 mg), and aztreonam
and clavulanic acid (30 mg and 10 mg). The differences in the zones
of inhibition caused by the cephalosporins alone and those com-
bined with clavulanic acid were recorded and, if the difference was
5 mm or more, the strains were conﬁrmed as ESBL-producing
strains [21].3. Results
3.1. Patient information
A total of 3584 patient blood samples were collected from
2008e2013. Of these 1465 (40.87%) were from male patients and
2119 (59.13%) were from females. The age distribution showed that
young children, neonates, and elderly patients were almost equally
susceptible to Salmonella infection in the blood. It is likely that their
immune systems are weaker than healthy adults and thus they are
prone to septicemia. The highest percentage of all patients with
clinically diagnosed enteric fever were in the 20e35 year age group
(29.19%), followed by the 36e50 year age group (26.62%) (Table 1).
Treatment histories of all enteric fever patients showed that the
highest percentage were from the gynecology department (26.4%)
followed bymedicine (19.89%), pediatrics (13.53%), surgery (8.34%),
and outpatient (17.91%) departments (Table 1). The age, sex, and
department of patients with Salmonella spp. in the bloodstream are
also shown in Table 1.3.2. Isolation and biochemical and serological identiﬁcation of
Salmonella spp.
A total of 328 samples of Salmonellawere isolated and identiﬁed
biochemically from 3584 blood samples. All the isolates showed
negative results in the ortho-nitrophenyl-b-galactoside, arginine
dihydrolase, citrate, urease, tryptophane deaminase, indole,
VogeseProskauer, gelatine, inositol, saccharose, and amylose tests,
and positive results in the lysine decarboxylase, ornithine decar-
boxylase, urease, hydrogen sulﬁde H2S, glucose, mannose, sorbose,
rhafﬁnose, mellibiose, and arabinose tests. In serology, 168 isolates
agglutinated with SEST polyvalent antisera and 160 isolates with
SESP polyvalent antisera, conﬁrming their identity.Table 1
Age, sex, and treatment distribution of total patients and bloodstream Salmonella
positive patients.
Parameter No. of patients (%) No. of Salmonella positive
patients (%)
Sex
Male 1465 (40.87) 150 (45.73)
Female 2119 (59.13) 178 (54.25)
Age group, y
<20 861 (24.02) 83 (25.30)
20e35 1046 (29.19) 102 (31.1)
36e50 954 (26.62) 79 (24.09)
>50 723 (20.17) 64 (19.51)
Treatment department
Pediatric 485 (13.53) 51 (15.54)
Medicine 713 (19.89) 61 (18.59)
Surgery 299 (8.34) 23 (7.01)
Obstetricegynecology 946 (26.4) 77 (23.48)
External 642 (17.91) 116 (35.36)
Total 3584 3283.3. Rates of SEST and SESP isolated from blood cultures
Distribution of illness by month and Salmonella prevalence are
shown in Table 2. Salmonella spp. were isolated throughout the
year, but the prevalence was comparatively low in the ﬁrst half
(JanuaryeJune) of the year. The prevalence showed a peak during
July, August, and September (Table 2).
The prevalence of Salmonella spp. from 2008 to 2013 showed a
gradual increase although the prevalence in 2010 (8.65%) and 2011
(8.18%) was slightly lower than in 2012 (9.2%) and 2013 (11.41%;
Fig. 1). Overall prevalence of Salmonella spp. in blood samples from
2008e2013 was 9.15%.
In 2008, there were fewer SEST isolates than SESP (Fig. 2), but
from 2009e2013, an increasing pattern of SEST isolates was
observed. In 2013, thereweremore SEST isolates (n¼ 39) than SESP
(n ¼ 33).
3.4. Sensitivity/resistance of Salmonella isolates to antimicrobial
compounds
Antibiotic resistance of isolated Salmonella spp. against the nine
antibiotics used increased each year from 2008e2013. Resistance to
amoxicillin was 37.5% in 2008, 41.29% in 2009, 37.29% in 2010,
35.29% in 2011, 37.28% in 2012, and 43.1% in 2013. Resistance rates
for other antibiotics in the same years were as follows: ceﬁpime
13.75%, 15.5%, 14.17%, 11.17%, 10.16%, and 16.34%; ceﬁxime 7.5%, 10%,
8.5%, 7.48%, 8.47%, and 11.2%; ceftriaxone 4.75%, 4.75%, 5.75%, 8.78%,
6.77%, and 9.1%; trimethoprimesulfamethoxazole 31.5%, 34.5%,
29%, 25.73%, 23.72%, and 33.65%; ciproﬂoxacin 25.75%, 28%, 25.5%,
21.43%, 25.42%, and 26.4%; nalidixic acid 75.6%, 77.5%, 76%, 77.67%,
79.66%, and 79.9%; and chloramphenicol 24%, 25.5%, 27.5%, 25.73%,
23.72%, and 31.35% in 2013. All the isolates were sensitive to mer-
openem from 2008e2013 (Fig. 3).
Comparison of antibiotic resistance showed relatively higher
resistance in S. paratyphi isolates than S. typhi (Figs. 4 and 5). Both
groups of organism showed higher resistsance to amoxicillin, tri-
methoprimesulfamethoxazole, ciproﬂoxacin, nalidixic acid, and
chloramphenicol than to other antibiotics. Resistance to ﬂur-
oquinolones such as ceﬁpime, ceﬁxime, and ceftriaxone increased
over the time studied. No resistance was observed against
meropenem.
3.5. MDR Salmonella patterns in blood cultures
MDR was found in 20.96% of Salmonella spp. isolates in total.
MDR rates in 2008 were 22.56%; in 2009, 19.14%; in 2010, 22.1%; in
2011, 18.41%; in 2012, 16.25%; and 27.31% in 2013 (Fig. 6).
The distribution of MDR Salmonella spp. in blood cultures by
month is shown in Table 3.
3.6. ESBL production
ESBL production was found in 57.01% of all Salmonella spp. iso-
lates, 54.17% of SEST isolates, and 60.625% of SESP isolates (Fig. 7).
4. Discussion
Typhoid fever caused by SEST and SESP is one of the most
common infections in Bangladesh [22]. Strains of SEST and SESP
resistant to commonly used antibiotics such as chloramphenicol,
amoxicillin, trimethoprimesulfamethoxazole, and ciproﬂoxacin
are emerging inmany parts of the world including Bangladesh [23].
Emerging antimicrobial drug resistance among bacterial pathogens
causing BSI can limit therapeutic options and complicate patient
management. The epidemiology of invasive bloodstream
Table 2
Month-wise distribution of illness and organisms during 2008e2013.
Parameter Month Total
Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
2008 Febrile Illness 19 29 27 46 39 45 77 91 55 29 19 23 499
Salmonella spp. 2 2 2 3 2 3 8 11 5 3 2 3 46
SEST 0 1 1 1 0 1 4 6 2 2 1 1 20
SESP 2 1 1 2 2 2 4 5 3 1 1 2 26
2009 Febrile Illness 21 32 29 45 39 55 88 97 55 33 37 21 552
Salmonella spp. 0 3 2 3 2 3 9 12 5 3 2 3 47
SEST 0 1 1 1 0 1 6 8 4 2 1 0 25
SESP 0 2 1 2 2 2 3 4 1 1 1 3 22
2010 Febrile Illness 45 33 21 35 29 45 99 105 65 40 47 19 583
Salmonella spp. 3 0 2 2 4 3 11 13 7 3 2 3 53
SEST 1 0 1 1 0 1 8 8 2 2 0 1 25
SESP 2 0 1 1 4 2 3 5 5 1 2 2 28
2011 Febrile Illness 29 31 41 45 32 48 103 98 75 40 55 21 618
Salmonella spp. 6 2 3 2 0 1 15 9 6 3 2 2 51
SEST 2 0 1 1 0 0 9 6 2 1 0 0 22
SESP 4 2 2 1 0 1 6 3 4 2 2 2 29
2012 Febrile Illness 37 31 45 29 44 48 104 103 88 40 52 23 644
Salmonella spp. 7 2 3 2 4 0 17 9 7 3 2 3 59
SEST 1 0 1 1 0 0 15 6 2 2 0 1 29
SESP 6 2 2 1 4 0 2 3 5 1 2 2 30
2013 Febrile Illness 41 44 36 28 48 58 86 105 99 112 107 94 858
Salmonella spp. 8 5 6 4 7 7 9 15 12 17 14 15 119
SEST 2 3 2 1 3 2 4 5 5 7 6 8 48
SESP 6 2 4 3 4 5 5 10 7 10 8 7 71
SESP ¼ Salmonella enterica serovars Typhi; SEST ¼ Salmonella enterica serovar Paratyphi.
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changes in the incidence and epidemiology of infecting organisms
have also brought about an increase in resistance tomany antibiotic
compounds, resulting in a reduction in therapeutic options [25].
Septicemia is one of themost severe invasive bacterial infections
and surveillance of antibiotic susceptibility of the organisms iso-
lated from blood cultures is an important method of obtaining in-
formation on resistance patterns at the regional and national level.
Because of variations in the susceptibility patterns of Salmonella
species from different geographical areas, constant monitoring is
important to provide suitable guidelines for successful treatment.
This study was carried out to show the antibiotic susceptibility
patterns of Salmonella strains (SEST and SESP) isolated from the
blood of typhoid patients in a tertiary care hospital in Dhaka,
Bangladesh. About 9.15% of the total samples were positive for
Salmonella spp. The prevalence increased gradually from 2008 to
2013 in accordance with other studies [26,27]. SEST (168 samples)
was more prevalent than SESP (160 samples). Salmonella infection
occurred throughout the year but the highest prevalencewas found
in JulyeDecember.
Neonates and young (age 2e15 years) and elderly persons (age
46e60 years) were more susceptible to Salmonella infection,
probably because of their weaker immune systems. Healthy adults
are less susceptible to BSI with Salmonella. Females had moreFig. 1. Prevalence of Salmonella spp. in blood, 2008e2013.infections than males and the same pattern was observed in Sal-
monella spp., SEST, and SESP infections.
A high percentage of the isolates showed resistance to ﬁrst line
(amoxicillin, chloramphenicol, trimethoprimesulfamethoxazole)
and second line drugs (nalidixic acid and ciproﬂoxacin). Resistance
to cephalosporins such as ceﬁpime, ceﬁxime, and ceftriaxone ten-
ded to increase during this period. No resistance was observed
against meropenem. Many researchers around the world have re-
ported increased resistance of Salmonella spp. against nalidixic acid
[28,29] and a dramatic increase in nalidixic acid-resistant isolates
was observed in this study.
Several previous studies reported bloodstream Salmonella spp.
in patients from Bangladesh. In one study [23], 66% of patients were
Salmonella spp. positive and one third of the isolated S. typhi were
MDR. The isolates were most resistant to amoxicillin, co-
trimoxazole, and chloramphenicol. In another study [30], among
304 of 385 (79%) isolated Salmonella spp. were S. typhi and 81 (21%)
were S. paratyphi. About 40% of the S. typhi isolates were resistant
to ampicillin, chloramphenicol, and co-trimoxazole compared with
only 1.8% of SESP. All SEST and SESP A were sensitive to ceftriaxone
[31]. Twelve MDR Salmonella isolates from hospital waste were
resistant to ciproﬂoxacin, ampicillin, amoxicillin, and penicillin. TheFig. 2. Comparative prevalence of Salmonella enterica serovar Typhi and Salmonella
enterica serovar Paratyphi in blood, 2008e2009.
Fig. 3. Antibiotic resistance pattern of isolated Salmonella spp., 2008e2009.
Fig. 5. Antibiotic resistance of Salmonella enterica serovar Paratyphi, 2008e2013.
Fig. 6. Multidrug resistant Salmonella spp. in blood, 2008e2013.
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tients with Salmonella. In another study, 943 SEST were isolated
from patients with typhoid fever and >50% of isolates were resis-
tant to ampicillin, co-trimoxazole, and chloramphenicol, and >90%
of isolates were resistant to nalidixic acid. Resistance to ciproﬂox-
acin was very low [32]. Similar results were also found in another
study [33] where resistance was higher to ampicillin, co-
trimoxazole, and chloramphenicol and all isolates were sensitive
to ceftriaxone and ceftazidime.
Most of the previous studies in Bangladesh on bloodstream
Salmonella spp. did not report detection of MDR Salmonella but in
this study, 20.92% of isolates were MDR. From 2008 to 2012, MDR
isolates decreased but in 2013 a sudden rise in the percentage of
MDR isolates was observed (Fig. 6). The distribution of MDR isolates
by month showed a higher prevalence from July to October each
year (Table 2), which is in accordance with the higher prevalence of
Salmonella spp. from July to December each year in this study
(Table 3). In one study [29], MDR Salmonella spp. prevalence was
37%, which is higher than in the present study. Mohanty et al [34]
also reported an increasing pattern of MDR Salmonella spp. in BSI.
In this study, ESBL production was observed in 57.01% of all
Salmonella spp. isolates, 54.17% of SEST isolates and 60.625% of SESP
isolates (Fig. 7). ESBL production was higher in this study than in
some previous studies. Irajian et al [35] reported ESBL production in
2% of SESP. This indicates an increasing trend of ESBL production in
bloodstream Salmonella spp. isolates in Bangladesh. ESBL Salmo-
nella spp. in a hospital setting is a challenge because of possible
spread of ESBL to other opportunistic pathogens and because of the
limited therapeutic options against them.Fig. 4. Antibiotic resistance of Salmonella enterica serovar Typhi, 2008e2013.This study in conjunctionwith previous studies warns about the
increasing prevalence of Salmonella BSI in a wide group of patients
and their increased resistance to ﬁrst line and second line drugs of
choice. Although the mortality rate linked to salmonellosis is low,
its high prevalence has signiﬁcant economic, epidemiological, and
health implications. Our data underscore the need for annual
antimicrobial resistance surveillance reports, which can provide
valuable insight into resistance trends at a particular medical fa-
cility to assist in the appropriate choice of empiric therapy.
Accurate prevalence rates and antibiotic resistant patterns of
bloodstream Salmonella spp. in Bangladesh cannot be ascertained
because of a lack of epidemiological surveillance systems at all
levels of government (federal, state, and local), and the presence of
other diseases considered to be of higher priority [11].Table 3
Multidrug resistant Salmonella pattern in blood culture, 2008e2013.
Month Multidrug resistance, %
2008 2009 2010 2011 2012 2013
January 0 50 25 16.67 14.286 16.45
February 50 0 0 0 0 11.32
March 33.333 0 0 0 0 25
April 0 0 50 50 50 0
May 0 33.333 33.333 33.33 25 33.33
June 25 0 0 0 0 33.33
July 30 23.077 13.333 14.286 11.765 25
August 28.571 25 22.22 22.222 22.222 25
September 40 33.333 40 40 28.571 0
October 33.33 50 50 50 13.333 0
November 0 0 0 0 0 33.33
December 25 25 25 0 0 25
Average 22.1 19.97 21.57 18.87 15.43 27.58
Fig. 7. Prevalence of extended-spectrum b-lactamase Salmonella spp. in blood,
2008e2013.
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probably contributed to the genesis of resistant SEST [36]. In Dhaka,
antimicrobials are available from chemist shops without legal
prescriptions. This encourages patients to buy antimicrobials over
the counter and use themwithout consulting a doctor. Appropriate
surveillance by monitoring antimicrobial drug susceptibility trends
is a prerequisite to implementing rational measures to tackle the
resistance problem. Continued surveillance of antimicrobial sus-
ceptibility patterns and study of MDR in Salmonella spp. in different
parts of the country will help in updating knowledge about the
proper antibiotics for therapeutic cure.
5. Conclusion
This study provided much needed information and warns about
the increasing prevalence of MDR SEST and SESP causing BSI in
Bangladesh. The rise in antibiotic resistance in blood isolates em-
phasizes the importance of sound hospital infection control,
rational prescribing policies, and the need for new antimicrobial
drugs and vaccines. Our data underscore the need for annual
antimicrobial resistance surveillance reports, which can provide
valuable insight into resistance trends at a particular medical fa-
cility to assist in the appropriate choice of empiric therapy.
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